BIOMARIN PHARMACEUTICAL INC (BMRN) Entity Common Stock, Shares Outstanding 2010 - 2024

Historical data

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Biomarin Pharmaceutical Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from 2010 to 2024.
  • Biomarin Pharmaceutical Inc Entity Common Stock, Shares Outstanding for the quarter ending April 22, 2024 was 190 M shares, a 1.16% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly Data (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 190 M +2.18 M +1.16% Apr 22, 2024 10-Q 2024-04-26
Q3 2023 188 M +2.52 M +1.36% Oct 30, 2023 10-Q 2023-11-02
Q2 2023 188 M +2.7 M +1.46% Jul 28, 2023 10-Q 2023-08-02
Q1 2023 188 M +2.71 M +1.46% Apr 25, 2023 10-Q 2023-04-28
Q3 2022 186 M +2.26 M +1.23% Oct 25, 2022 10-Q 2022-10-28
Q2 2022 185 M +2.12 M +1.16% Jul 28, 2022 10-Q 2022-08-04
Q1 2022 185 M +2.25 M +1.23% Apr 25, 2022 10-Q 2022-04-29
Q3 2021 184 M +2.06 M +1.14% Oct 26, 2021 10-Q 2021-10-29
Q2 2021 183 M +2 M +1.1% Jul 27, 2021 10-Q 2021-07-30
Q1 2021 183 M +1.91 M +1.05% Apr 21, 2021 10-Q 2021-04-30
Q4 2020 182 M +1.9 M +1.06% Feb 12, 2021 10-K 2021-02-26
Q3 2020 182 M +1.9 M +1.06% Oct 23, 2020 10-Q 2020-11-06
Q2 2020 181 M +1.89 M +1.05% Jul 30, 2020 10-Q 2020-08-05
Q1 2020 181 M +1.77 M +0.99% Apr 20, 2020 10-Q 2020-05-01
Q4 2019 180 M +1.55 M +0.87% Feb 12, 2020 10-K 2020-02-27
Q3 2019 180 M +1.56 M +0.88% Oct 18, 2019 10-Q/A 2019-11-04
Q2 2019 179 M +1.87 M +1.05% Jul 22, 2019 10-Q 2019-08-02
Q1 2019 179 M +2.36 M +1.33% Apr 15, 2019 10-Q 2019-04-29
Q4 2018 178 M +2.3 M +1.31% Feb 12, 2019 10-K 2019-02-28
Q3 2018 178 M +2.44 M +1.39% Oct 19, 2018 10-Q 2018-10-26
Q2 2018 178 M +2.32 M +1.33% Jul 23, 2018 10-Q 2018-08-03
Q1 2018 177 M +2.22 M +1.27% Apr 13, 2018 10-Q 2018-04-27
Q4 2017 176 M +3.21 M +1.85% Feb 13, 2018 10-K 2018-02-26
Q3 2017 176 M +3.63 M +2.11% Oct 25, 2017 10-Q 2017-10-31
Q2 2017 175 M +11.8 M +7.22% Jul 20, 2017 10-Q 2017-08-02
Q1 2017 174 M +12.2 M +7.5% Apr 20, 2017 10-Q 2017-05-04
Q4 2016 173 M +11.3 M +6.98% Feb 13, 2017 10-K 2017-02-27
Q3 2016 172 M +10.7 M +6.66% Oct 28, 2016 10-Q 2016-11-03
Q2 2016 163 M +2.37 M +1.47% Jul 29, 2016 10-Q 2016-08-08
Q1 2016 162 M +1.99 M +1.24% Apr 22, 2016 10-Q 2016-05-02
Q4 2015 162 M +2.45 M +1.54% Feb 12, 2016 10-K 2016-02-29
Q3 2015 161 M +13.8 M +9.35% Oct 23, 2015 10-Q 2015-11-02
Q2 2015 161 M +14 M +9.5% Jul 27, 2015 10-Q 2015-08-05
Q1 2015 160 M +14.4 M +9.88% Apr 24, 2015 10-Q 2015-05-05
Q4 2014 159 M +15.5 M +10.8% Feb 13, 2015 10-K 2015-03-02
Q3 2014 147 M +5.25 M +3.69% Oct 18, 2014 10-Q 2014-10-28
Q2 2014 147 M +7.01 M +5% Jul 18, 2014 10-Q 2014-07-31
Q1 2014 146 M +6.92 M +4.98% Apr 18, 2014 10-Q 2014-05-02
Q4 2013 144 M Feb 14, 2014 10-K 2014-02-26
Q3 2013 142 M +18.4 M +14.8% Oct 18, 2013 10-Q 2013-10-28
Q2 2013 140 M +16.6 M +13.4% Jul 19, 2013 10-Q 2013-07-29
Q1 2013 139 M +23.3 M +20.1% Apr 19, 2013 10-Q 2013-04-29
Q3 2012 124 M +9.61 M +8.42% Oct 12, 2012 10-Q 2012-10-29
Q2 2012 124 M +11.7 M +10.5% Jul 13, 2012 10-Q 2012-08-02
Q1 2012 116 M +4.79 M +4.32% Apr 13, 2012 10-Q 2012-04-30
Q4 2011 115 M Feb 13, 2012 10-K 2012-02-22
Q3 2011 114 M +11.7 M +11.4% Oct 15, 2011 10-Q 2011-10-31
Q2 2011 112 M +9.77 M +9.57% Jul 15, 2011 10-Q 2011-08-01
Q1 2011 111 M Apr 15, 2011 10-Q 2011-04-29
Q3 2010 102 M Oct 22, 2010 10-Q 2010-10-29
Q2 2010 102 M Jul 23, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.